Abiopharma

New Form SCHEDULE 13G/A - enGene Therapeutics Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0002005369-26-000051 <b>Size:</b> 18 KB

(30% Negative) CINGULATE INC. (CINGW) Reports Q3 2026 Financial Results

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088876 <b>Size:</b> 142 KB

New Form SCHEDULE 13G - DENTSPLY SIRONA Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000199 <b>Size:</b> 8 KB

New Form FWP - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039786 <b>Size:</b> 148 KB

Financial Statements and Related Announcement: Half Yearly Results

New Form SCHEDULE 13G - DraftKings Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000198 <b>Size:</b> 8 KB

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023673 <b>Size:</b> 1 MB

(30% Negative) PDS BIOTECHNOLOGY CORP (PDSB) Reports Q3 2026 Financial Results

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023671 <b>Size:</b> 1 MB

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039785 <b>Size:</b> 998 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039784 <b>Size:</b> 611 KB

New Form SCHEDULE 13G - Gesher Acquisition Corp. II <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000197 <b>Size:</b> 10 KB

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023669 <b>Size:</b> 1 MB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039783 <b>Size:</b> 1 MB